The Journal of Practical Medicine >
Expression of NLRP3 inflammatory vesicles, Cav-1, and S1P1 in children with Kawasaki disease and their association with coronary artery injury
Received date: 2025-04-11
Online published: 2025-07-18
Objective To explore the expression of peripheral blood Nod-like receptor protein 3 (NLRP3) inflammasomes, serum caveolin-1 (Cav-1), and sphingosine 1-phosphate receptor 1 (S1P1) in children with Kawasaki disease (KD), and to elucidate their associations with coronary artery lesion (CAL). Methods A total of 223 children diagnosed with KD were recruited from our hospital between March 2023 and December 2024 and served as the KD study group. These children were classified into the CAL group (n = 71) and the non-CAL group (n = 152) based on their CAL status. Additionally, 223 healthy children who underwent physical examinations at our hospital were selected as the healthy control group. Clinical data, levels of routine laboratory test indices, peripheral blood NLRP3 inflammasomes, serum Cav-1, and S1P1 were compared among the groups. Risk factors for CAL in children with KD were analyzed, and the diagnostic value of peripheral blood NLRP3 inflammasomes, serum Cav-1, and S1P1 levels for CAL in children with KD was evaluated. Results The levels of NLRP3, caspase-1, ASC in peripheral blood and messenger ribonucleic acid (mRNA) of serum Cav-1 were significantly higher in the KD study group than in the healthy control group (P < 0.05). Conversely, the serum level of S1P1 was significantly lower in the KD study group compared to the healthy control group (P < 0.05). In the CAL group, the levels of peripheral blood white blood cell count (WBC), NLRP3, caspase-1, ASC mRNA, serum C-reactive protein (CRP), and Cav-1 were all higher than those in the non-CAL group (P < 0.05), while the serum level of S1P1 was lower than that in the non-CAL group (P < 0.05). The levels of NLRP3, caspase-1, ASC mRNA in peripheral blood, along with serum Cav-1 and S1P1, were identified as independent risk factors for CAL in children with KD (P < 0.05). The results of receiver operating characteristic (ROC) analysis indicated that the combined test of the levels of NLRP3, caspase-1, ASC mRNA in peripheral blood, serum Cav-1, and S1P1 for diagnosing CAL in children with KD had an area under the curve (AUC) value of 0.926. This value was significantly higher than that of each individual index (0.844, 0.785, 0.821, 0.843, 0.833, P < 0.05). Conclusions The levels of NLRP3 inflammatory vesicles in peripheral blood and serum Cav-1 were highly expressed in children with KD, whereas the serum S1P1 was poorly expressed. These indices may be involved in the development process of CAL in children with KD. Moreover, the combination of these indices is more beneficial for the diagnosis of CAL in children with KD.
Bin DENG , Ailian WANG , Boli CHENG , Jiahao CHEN , Yun HE , Chonghai. LIU . Expression of NLRP3 inflammatory vesicles, Cav-1, and S1P1 in children with Kawasaki disease and their association with coronary artery injury[J]. The Journal of Practical Medicine, 2025 , 41(13) : 2094 -2099 . DOI: 10.3969/j.issn.1006-5725.2025.13.022
| [1] | 吕爱婷, 叶岚, 储晨,等. 儿童川崎病严重冠状动脉病变合并心肌梗死41例分析 [J]. 中华儿科杂志, 2025, 63(2): 157-162. |
| [2] | 张锰, 崔青, 朱荻绮, 等. 川崎病合并冠状动脉病变患儿21例冠状动脉造影复查分析 [J]. 上海交通大学学报(医学版), 2023, 43(12): 1535-1541. |
| [3] | 孙佳莹, 付茜, 辛雨, 等. QT离散度对川崎病患儿发生冠状动脉损伤及其预后的预测价值 [J]. 中国医科大学学报, 2023, 52(3): 193-198. |
| [4] | JI M L, DONG J Y, XU Y, et al. Inositol-triphosphate 3-kinase c and dna methylation involvement in nlrp3 inflammasome activation in kawasaki disease [J]. Indian J Pediatr, 2023, 90(1): 22-28. doi:10.1007/s12098-022-04126-y |
| [5] | ZHANG Y, LIU J. Clinical value of echocardiography combined with serum cav-1, nfatc1, and pai-1 in the diagnosis of kawasaki disease complicated with coronary artery lesions [J]. Heart Vessels, 2024, 39(1): 18-24. doi:10.1007/s00380-023-02315-z |
| [6] | HLA T, VENKATARAMAN K, MICHAUD J, et al. S1p signaling in immunity and vascular disease: Implications for kawasaki disease [J]. Circ Res, 2022, 130(6): 925-940. |
| [7] | 江载芳, 申昆玲, 沈颖, 等. 诸福棠实用儿科学 [M]. 9版. 北京: 人民卫生出版社, 2022: 774-775. |
| [8] | ONOUCHI Y. Genetics of kawasaki disease and coronary artery aneurysms [J]. Pediatr Int, 2023, 65(1): 15453. |
| [9] | 张华勇, 张勇. 5岁以上川崎病儿童合并冠状动脉病变的预测指标与风险模型构建 [J]. 中国当代儿科杂志, 2024, 26(5): 461-468. |
| [10] | 曾莉. 免疫调节因子PK2在川崎病中的作用及机制研究 [D]. 重庆: 重庆医科大学, 2024. |
| [11] | 俞灵盈. 中性粒细胞胞外捕获网介导川崎病血管损伤的机制研究 [D]. 遵义: 遵义医科大学, 2021. |
| [12] | 曹金鑫. 激肽原1和精氨酸酶1对川崎病冠状动脉损伤的预测价值 [D]. 沈阳: 中国医科大学, 2023. |
| [13] | 钱翠平, 黄晓碧, 赵胜, 等. 儿童川崎病冠状动脉损伤危险因素Logistic回归分析 [J]. 安徽医科大学学报, 2023, 58(3): 490-494. |
| [14] | SHAHI A, AFZALI S, FIROOZI Z, et al. Potential roles of nlrp3 inflammasome in the pathogenesis of kawasaki disease [J]. J Cell Physiol, 2023, 238(3): 513-532. doi:10.1002/jcp.30948 |
| [15] | 汤嘉琪. HAdV-7和HAdV-3感染激活NLRP3炎症小体的差异性研究 [D]. 广州: 广州医科大学, 2024. |
| [16] | 闫俊臣. 氧化三甲胺通过AT1R介导NLRP3炎症小体促进动脉平滑肌细胞焦亡 [D]. 呼和浩特: 内蒙古医科大学, 2024. |
| [17] | 付希广. 颈动脉斑块中NLRP3炎症小体表达量与斑块组织学特征相关性的研究 [D]. 济南: 山东大学, 2023. |
| [18] | LEE Y, WAKITA D, DAGVADORJ J, et al. NLRP3 inflammasome activation contributes to the pathogenesis of Kawasaki disease [J]. Arthritis & Rheumatol, 2021, 73(1): 151-160. |
| [19] | CHEN A C, LAI S C, LU C Y, et al. Exploration of the molecular mechanism by which caveolin-1 regulates changes in blood-brain barrier permeability leading to eosinophilic meningoencephalitis [J]. Trop Med Infect Dis, 2024, 9(6): 124-124. doi:10.3390/tropicalmed9060124 |
| [20] | VAN REGEMORTER E, JORIS V, et al. Downregulation of caveolin-1 and upregulation of deiodinase 3, associated with hypoxia-inducible factor-1α increase, are involved in the oxidative stress of graves' orbital adipocytes [J]. Thyroid, 2021, 31(4): 627-637. doi:10.1089/thy.2020.0238 |
| [21] | CHEN Z, RUAN B, LONG G, et al. Adipose tissue-derived mesenchymal stem cells attenuate lung inflammation and fibrosis in the bleomycin-induced pulmonary fibrosis rat model via caveolin-1/nf-kb signaling axis [J]. Physiol Res, 2022, 71(5): 657-666. |
| [22] | ZHU F, HUANG J, WANG X, et al. The expression and significance of serum caveolin-1 in patients with kawasaki disease [J]. Chin J Physiol, 2020, 63(2): 90-94. doi:10.4103/cjp.cjp_71_19 |
| [23] | ZHANG Y, WANG Y, LI X, et al. S1p1 receptor modulation attenuates vascular inflammation in a murine model of kawasaki disease [J]. J Immunol, 2022, 208(3): 567-576. |
| [24] | CHUA X Y, HO L T Y, XIANG P, et al. Preclinical and clinical evidence for the involvement of sphingosine 1-phosphate signaling in the pathophysiology of vascular cognitive impairment [J]. Neuromolecular Med, 2021, 23(1): 47-67. doi:10.1007/s12017-020-08632-0 |
| [25] | RIESE J, GROMANN A, LüHRS F, et al. Sphingosine-1-phosphate receptor type 4 (s1p(4)) is differentially regulated in peritoneal b1 b cells upon tlr4 stimulation and facilitates the egress of peritoneal b1a b cells and subsequent accumulation of splenic ira b cells under inflammatory conditions [J]. Int J Mol Sci, 2021, 22(7): 3465-3465. doi:10.3390/ijms22073465 |
/
| 〈 |
|
〉 |